Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature
Iatrogenic immunodeficiency-associated lymphoproliferative disorders (LPDs) are heterogeneous clinicopathological entities developing in patients receiving immunosuppression. Outside the posttransplant setting, methotrexate (MTX), a drug commonly used for the treatment of autoimmune diseases, is an...
Saved in:
Main Authors: | Carolina Afonso, Adriana Roque, Cátia Almeida, Maria Beatriz Pimentão, Maria José Julião, Rodolfo Silva, Catarina Geraldes, Marília Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/7178065 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nitric Oxide Levels in Patients with Psoriasis Treated with Methotrexate
by: Nilgun Solak Tekin, et al.
Published: (2006-01-01) -
Nitric Oxide Levels in Patients with Psoriasis Treated with Methotrexate
Published: (2006-01-01) -
The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
by: Huynh Thi Xuan Tam, et al.
Published: (2022-01-01) -
Thymic Hyperplasia after Lung Transplantation Imitating Posttransplant Lymphoproliferative Disorder
by: Christina Maria Steger, et al.
Published: (2011-01-01) -
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)